Rick is a cell and molecular biologist by training, gaining his PhD at McGill University, Canada. This was followed by a postdoctorate at the Imperial Cancer Research Fund, London, and then the National Institute for Medical Research. He left to join AstraZeneca as a team leader in the Department of Target Discovery, then worked for SanofiAventis as a Senior Team leader. In 2001 he left SanofiAventis and joined Impharmatica as Associate Director Target Discovery and worked very closely with the business development team. In 2006 he joined UCLB as Assistant Director BioPharm, becoming Director in 2007.